Douglas E Williams - Net Worth and Insider Trading
Douglas E Williams Net Worth
The estimated net worth of Douglas E Williams is at least $2 Million dollars as of 2024-11-06. Douglas E Williams is the EVP Research & Development of Biogen Inc and owns about 11,817 shares of Biogen Inc (BIIB) stock worth over $2 Million. Douglas E Williams is the Director of Ovid Therapeutics Inc and owns about 5,000 shares of Ovid Therapeutics Inc (OVID) stock worth over $6,250. Douglas E Williams is also the President & CEO of Codiak BioSciences Inc and owns about 7,655 shares of Codiak BioSciences Inc (CDAKQ) stock worth over $12. Details can be seen in Douglas E Williams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas E Williams has not made any transactions after 2023-03-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas E Williams
Douglas E Williams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas E Williams owns 9 companies in total, including Codiak BioSciences Inc (CDAKQ) , Ovid Therapeutics Inc (OVID) , and Ironwood Pharmaceuticals Inc (IRWD) among others .
Click here to see the complete history of Douglas E Williams’s form 4 insider trades.
Insider Ownership Summary of Douglas E Williams
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CDAKQ | Codiak BioSciences Inc | 2023-03-28 | director & President & CEO |
OVID | Ovid Therapeutics Inc | 2018-08-14 | director |
IRWD | Ironwood Pharmaceuticals Inc | 2014-06-03 | director |
2012-11-05 | director | ||
2015-06-19 | EVP Research & Development | ||
2013-06-13 | director | ||
2003-09-30 | director & CSO & EVP R&D | ||
2021-04-06 | director | ||
2023-04-10 | EVP & President & R&D |
Douglas E Williams Latest Holdings Summary
Douglas E Williams currently owns a total of 3 stocks. Among these stocks, Douglas E Williams owns 11,817 shares of Biogen Inc (BIIB) as of June 19, 2015, with a value of $2 Million and a weighting of 99.7%. Douglas E Williams owns 5,000 shares of Ovid Therapeutics Inc (OVID) as of August 14, 2018, with a value of $6,250 and a weighting of 0.3%. Douglas E Williams also owns 7,655 shares of Codiak BioSciences Inc (CDAKQ) as of March 28, 2023, with a value of $12 and a weighting of 0%.
Latest Holdings of Douglas E Williams
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BIIB | Biogen Inc | 2015-06-19 | 11,817 | 176.93 | 2,090,782 |
OVID | Ovid Therapeutics Inc | 2018-08-14 | 5,000 | 1.25 | 6,250 |
CDAKQ | Codiak BioSciences Inc | 2023-03-28 | 7,655 | 0.00 | 12 |
Holding Weightings of Douglas E Williams
Douglas E Williams Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas E Williams has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 3,841 shares on June 19, 2015, which brought Douglas E Williams around $2 Million.
According to the SEC Form 4 filings, Douglas E Williams has made a total of 0 transactions in Ovid Therapeutics Inc (OVID) over the past 5 years. The most-recent trade in Ovid Therapeutics Inc is the acquisition of 5,000 shares on August 14, 2018, which cost Douglas E Williams around $32,450.
According to the SEC Form 4 filings, Douglas E Williams has made a total of 3 transactions in Codiak BioSciences Inc (CDAKQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Codiak BioSciences Inc is the sale of 41,667 shares on March 28, 2023, which brought Douglas E Williams around $7,500.
Insider Trading History of Douglas E Williams
- 1
Douglas E Williams Trading Performance
GuruFocus tracks the stock performance after each of Douglas E Williams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas E Williams is -30.38%. GuruFocus also compares Douglas E Williams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas E Williams within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas E Williams's insider trading performs compared to the benchmark.
Performance of Douglas E Williams
Douglas E Williams Ownership Network
Ownership Network List of Douglas E Williams
Ownership Network Relation of Douglas E Williams
Douglas E Williams Owned Company Details
What does Codiak BioSciences Inc do?
Who are the key executives at Codiak BioSciences Inc?
Douglas E Williams is the director & President & CEO of Codiak BioSciences Inc. Other key executives at Codiak BioSciences Inc include See Remarks Yalonda Howze , Chief Scientific Officer Sriram Sathyanarayanan , and See Remarks Nicole Barna .
Codiak BioSciences Inc (CDAKQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Codiak BioSciences Inc Insider Transactions
Douglas E Williams Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas E Williams. You might contact Douglas E Williams via mailing address: C/o Amgen Inc, One Amgen Center Dr, Thousand Oaks Ca 91320-1799.